P
PathAI
Biotech & Life Sciences · Boston, United States · Founded 2016
AI-powered pathology platform optimizing diagnostic accuracy and research MoreLess
PathAI is dedicated to improving patient outcomes through its AI-powered pathology platform. The company focuses on enhancing the accuracy of diagnoses and the efficacy of treatments for diseases such as cancer by leveraging advanced machine learning techniques. PathAI serves healthcare providers, research institutions, and pharmaceutical companies, operating primarily in the medical and healthcare markets. The business model revolves around providing AI-driven diagnostic tools and services, generating revenue through partnerships, licensing, and service fees. The company is headquartered in Fenway and boasts a diverse team committed to solving complex problems and making a significant impact. PathAI has also been recognized as one of BBJ's Best Places to Work.
Keywords: AI, pathology, diagnosis, treatment, cancer, machine learning, healthcare, medical, patient outcomes, Fenway.
Talent graph
PathAI's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where PathAI has talent and traffic
team presence
Market sentiment
What the market is saying about PathAI
An AI-synthesized read of the highest-engagement posts about PathAI on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PathAI on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.















